Stocks
Nektar Therapeutics (NKTR) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -453.2% | -351.8% | -269.8% | -88.1% | -234.9% | -215.9% | ||
| Changes by years, y/y, % | -195pp | +101pp | +82pp | +182pp | -147pp | -1.8% | |||
Nektar Therapeutics. EBITDA margin, %
Nektar Therapeutics. EBITDA margin, changes, pp
Nektar Therapeutics (NKTR) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -391.7% | -302.3% | -248.6% | -86.7% | -350.9% | -215.9% | |
| Changes by years, y/y, % | -254pp | -113pp | -124pp | -147pp | +41pp | |||
| Changes by quarters, q/q, % | -452pp | +89pp | +54pp | +162pp | -264pp | |||
